New Clinical Trials For Stage IV Breast Cancer
New clinical trials for stage 4 breast cancer are available. See clinical trials for HR-positive, triple-negative, and other subtypes.
New clinical trials for stage 4 breast cancer are available. See clinical trials for HR-positive, triple-negative, and other subtypes.
Some MBC treatments can cause or increase the risk of heart problems. Read more about research studying how to monitor and treat cardiotoxicity.
Read for information on the FDA’s expanded approval of Trodelvy® and ASCO’s updated guidance on the use of this drug.
Many clinical trials study ways to improve quality of life, manage side effects, and advance cancer research. Learn more here.
Click for an overview of information from the symposium highlighting the need for increased diversity in clinical trials.
Click to learn about elacestrant (Orserdu™) as well as the Guardant360 blood test that identifies people likely to benefit from the drug.
for past articles or specific information.